Alyce Chen

Associate

alyce-chen
  • JD, cum laude, Boston University School of Law, 2015
  • BS (Business Administration), Boston University Questrom School of Business, 2011

Qualifications

  • Hong Kong, Registered Foreign Lawyer (Massachusetts), 2022
  • New York, 2016
  • Massachusetts, 2015
  • Chinese (Mandarin - Fluent)
  • English (Native)
  • Boston Bar Association
  • Director, Asian American Lawyers Association of Massachusetts (2018-2019)
  • Vice Chair, National Asian Pacific American Bar Association International Committee (2020-present)
  • Legal 500 (2022-2023)

Alyce Chen

Associate

View Chinese version.

Alyce Chen advises multinational life sciences companies on a range of strategic transactions, including cross-border mergers and acquisitions, equity and cooperative joint ventures, venture capital financings and public offerings.

Prior to joining Ropes & Gray, Alyce was an associate in the Boston headquarters of another global law firm, where she counseled public and private companies in the technology, life sciences and financial services sectors.

Experience

  • Advised numerous life sciences and consumer goods companies in venture financing transactions from formation to exit and on corporate governance, intellectual property, and other ongoing commercial matters.
  • Advised public companies in the life sciences and technology sectors on public company and securities compliance, including on Nasdaq and Hong Kong Stock Exchange compliance matters.
  • Represented various venture capital firms investing in companies in the life sciences and consumer goods sectors in the U.S. and the Asia-Pacific region.
  • Represented various multinational companies, including Johnson & Johnson and Fibrogen, in mergers, acquisitions, joint ventures and divestitures in the Asia-Pacific region.
  • Advised LianBio, a company launched by life sciences investment firm Perceptive Advisors, in its formation, fundraising activities in the U.S. and China (including its $310 million crossover financing), bespoke strategic platform collaborations with Pfizer and BridgeBio and $325 million IPO of American depository shares on Nasdaq.

Publications

  • Co-author, “Preparing For Your Cross-Border Deal: Practice Tips for In-house Counsel,” ACC Docket (June 2017)

Qualifications

  • Hong Kong, Registered Foreign Lawyer (Massachusetts), 2022
  • New York, 2016
  • Massachusetts, 2015
  • Legal 500 (2022-2023)
Cookie Settings